HDAC Inhibitors Market Sees Upward Trajectory Across the 7MM During the Forecast Period (2025-2034) Driven by Innovation in Cancer Therapies | DelveInsight
The HDAC inhibitor pipeline remains active, with several next-generation agents advancing in clinical trials. Abexinostat (Xynomic Pharmaceuticals) is in Phase III development for renal cell carcinoma, representing a potential expansion into solid tumors. Quisinostat (Viriom) is in Phase II for uveal melanoma, and Entinostat, partnered between EOC Pharma and Syndax, is being explored in Hodgkin […]
GALIANO GOLD REPORTS EXCEPTIONAL DRILL RESULTS AT ABORE, INCLUDING 23m @ 6.8 g/t Au AND 16.4m @ 5.3 g/t Au, WITH MULTIPLE ORE SHOOTS AND NEW HIGH-GRADE ZONE IDENTIFIED
Multiple new high-grade gold intercepts below the Mineral Resource at Abore highlight potential for Mineral Resource growth. VANCOUVER, BC, Aug. 20, 2025 /PRNewswire/ – Galiano Gold Inc. (“Galiano” or the “Company”) (TSX: GAU) (NYSE American: GAU) is pleased to announce an update on the Abore 2025 Phase 2 drilling program, currently underway at the Asanko Gold Mine […]
First Horizon Foundation Provides $25,000 to Red Cross to Support Relief Efforts in Chattanooga
This funding will support a wide range of essential services and resources in the community. CHATTANOOGA, Tenn., Aug. 20, 2025 /PRNewswire/ — First Horizon Foundation announced today a $25,000 donation to the American Red Cross of Southeast Tennessee to support relief efforts in Chattanooga. The funds will directly benefit the community by helping to provide with […]
CTO Realty Growth, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the CTO Class Action
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (NYSE: CTO) securities between February 18, 2021 and June 24, 2025. CTO is a publicly traded real estate investment trust (“REIT“) that owns and operates a […]
Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology. The […]
ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between August 10, 2023 and June 25, 2025. Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity, metabolic and liver diseases. […]
NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/S
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (NYSE: NVO) securities between May 7, 2025 and July 28, 2025. Novo Nordisk is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical […]
LINE STOCK: Robbins LLP Reminds LINE Stockholders of the Opportunity to Lead to the Class Action Lawsuit Against Lineage, Inc.
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with the Company’s 2024 initial public offering (“IPO”). Lineage is a Maryland REIT focused on temperature-controlled cold-manage […]
CENTENE CORPORATION RECOMMENDS STOCKHOLDERS REJECT “MINI-TENDER” OFFER FROM TRC CAPITAL INVESTMENT CORPORATION
ST. LOUIS, Aug. 20, 2025 /PRNewswire/ — Centene Corporation (NYSE: CNC) (Centene) announced today that it received notice of an unsolicited “mini-tender” offer from TRC Capital Investment Corporation (TRC) dated August 5th, 2025. Centene is in no way affiliated with TRC. TRC has offered to purchase up to 4 million shares of Centene’s common stock at […]
KASOWITZ LLP: ENVESTNET, INC. WAS FOUND TO HAVE ACTIVELY PARTICIPATED IN SPOLIATION AND NOW FACES A DELAWARE JURY TRIAL ON FINANCIALAPPS’ $100 MILLION TRADE SECRET MISAPPROPRIATION CLAIM
NEW YORK, Aug. 20, 2025 /PRNewswire/ — Six years into a $100 million lawsuit brought by Kasowitz LLP on behalf of fintech pioneer FinancialApps, LLC against defendants Envestnet, Inc. and Yodlee, Inc. for trade secret misappropriation, tortious interference, and unfair competition, a Special Master appointed by the Delaware District Court has recommended formal sanctions against both Envestnet (recently acquired […]